These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 17059084

  • 1. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF.
    Ned Tijdschr Geneeskd; 2006 Sep 30; 150(39):2127-30. PubMed ID: 17059084
    [Abstract] [Full Text] [Related]

  • 2. Statins and stroke prevention.
    Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J.
    Cerebrovasc Dis; 2007 Sep 30; 24(2-3):170-82. PubMed ID: 17596685
    [Abstract] [Full Text] [Related]

  • 3. Statin therapy and stroke prevention: what was known, what is new and what is next?
    Mazighi M, Lavallée PC, Labreuche J, Amarenco P.
    Curr Opin Lipidol; 2007 Dec 30; 18(6):622-5. PubMed ID: 17993806
    [Abstract] [Full Text] [Related]

  • 4. Stroke prevention, blood cholesterol and statins.
    Amarenco P, Lavallée PC, Labreuche J, Touboul PJ.
    Acta Neurol Taiwan; 2005 Sep 30; 14(3):96-112. PubMed ID: 16252611
    [Abstract] [Full Text] [Related]

  • 5. Statins and stroke prevention.
    Paciaroni M, Bogousslavsky J.
    Expert Rev Cardiovasc Ther; 2009 Oct 30; 7(10):1231-43. PubMed ID: 19814666
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of cardiovascular complications after a stroke or TIA: hypotensive and hypocholesterolemic therapy].
    Dippel DW, van der Worp HB.
    Ned Tijdschr Geneeskd; 2004 Apr 24; 148(17):820-4. PubMed ID: 15141647
    [Abstract] [Full Text] [Related]

  • 7. [Statins and stroke].
    Chudzik W, Kaczorowska B, Chmielewski H, Przybyła M, Gałka M.
    Pol Merkur Lekarski; 2005 Oct 24; 19(112):591-5. PubMed ID: 16379334
    [Abstract] [Full Text] [Related]

  • 8. Statins for stroke prevention: disappointment and hope.
    Amarenco P, Tonkin AM.
    Circulation; 2004 Jun 15; 109(23 Suppl 1):III44-9. PubMed ID: 15198966
    [Abstract] [Full Text] [Related]

  • 9. [Statins in stroke prevention].
    Gedikli O, Baykan M.
    Anadolu Kardiyol Derg; 2008 Jun 15; 8(3):217-22. PubMed ID: 18524729
    [Abstract] [Full Text] [Related]

  • 10. Drug insight: translating evidence on statin therapy into clinical benefits.
    Sanossian N, Ovbiagele B.
    Nat Clin Pract Neurol; 2008 Jan 15; 4(1):43-9. PubMed ID: 18199996
    [Abstract] [Full Text] [Related]

  • 11. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT.
    QJM; 2005 Aug 15; 98(8):599-614. PubMed ID: 16006501
    [Abstract] [Full Text] [Related]

  • 12. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
    Schwertz DW, Badellino KO.
    J Cardiovasc Nurs; 2008 Aug 15; 23(1):8-13. PubMed ID: 18158500
    [Abstract] [Full Text] [Related]

  • 13. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X, Giral P.
    Curr Med Res Opin; 2004 Jul 15; 20(7):1137-42. PubMed ID: 15265258
    [Abstract] [Full Text] [Related]

  • 14. Management of cholesterol to reduce the burden of stroke in Asia: consensus statement.
    Hankey GJ, Wong KS, Chankrachang S, Chen C, Crimmins D, Frayne J, Kim JS, Li Y, Liou CW, Merican JS, Misbach J, Navarro J, Shinohara Y, Wang Y, Yoon BW, Working Group on Stroke and Lipids Management in Asia Consensus Panel.
    Int J Stroke; 2010 Jun 15; 5(3):209-16. PubMed ID: 20536617
    [Abstract] [Full Text] [Related]

  • 15. Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary prevention.
    Fuentes B, Ortega-Casarrubios MA, Martínez P, Díez-Tejedor E.
    Cerebrovasc Dis; 2007 Jun 15; 24 Suppl 1():96-106. PubMed ID: 17971644
    [Abstract] [Full Text] [Related]

  • 16. Stroke prevention: management of modifiable vascular risk factors.
    Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-Cordoliani MA, Lucas C, Bordet R.
    J Neurol; 2002 May 15; 249(5):507-17. PubMed ID: 12021938
    [Abstract] [Full Text] [Related]

  • 17. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D, Collet JP, Cottin Y, Cournot M, Ducimetière P, Ferrières J, Paillard F, Valensi P, Zeller M, Cambou JP.
    Arch Mal Coeur Vaiss; 2007 Jan 15; 100 Spec No 1():57-64. PubMed ID: 17405566
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H, Treating to New Targets (TNT) Steering Committee and Investigators.
    Am J Cardiol; 2007 Sep 01; 100(5):747-52. PubMed ID: 17719314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.